Patents by Inventor Marc Barry Taub

Marc Barry Taub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230352126
    Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.
    Type: Application
    Filed: July 12, 2023
    Publication date: November 2, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
  • Publication number: 20230317276
    Abstract: Method and apparatus including calling, retrieving and/or initiating a programmed function in conjunction with execution of one or more commands related to a closed loop control algorithm, receiving one or more data in response to the one or more commands over a data interface, and executing the one or more commands related to the closed loop control algorithm based on the received one or more data are provided.
    Type: Application
    Filed: April 3, 2023
    Publication date: October 5, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc Barry TAUB, Daniel Milfred BERNSTEIN, Gary Alan HAYTER, Mark Kent SLOAN, Glenn Howard BERMAN, Saeed NEKOOMARAM
  • Publication number: 20230268071
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: February 28, 2023
    Publication date: August 24, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Patent number: 11735295
    Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: August 22, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
  • Publication number: 20230238131
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: April 3, 2023
    Publication date: July 27, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20230210413
    Abstract: Methods and Devices to monitor the level of at least one analyte are provided.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 6, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Jolyon Robert Bugler, Thomas A. Peyser
  • Publication number: 20230210406
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 6, 2023
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Patent number: 11678821
    Abstract: Methods and Devices to monitor the level of at least one analyte are provided.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: June 20, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Jolyon Robert Bugler, Thomas A. Peyser
  • Patent number: 11621073
    Abstract: A method of providing treatment for a medical condition includes storing a plurality of closed loop control algorithms in memory accessible by the control unit and receiving. A control unit receives analyte data from an analyte sensor in communication with the control unit. The control unit controls a medication delivery device in accordance with the first closed loop control algorithm based on the analyte data. The control unit causes the medication delivery device to be controlled in accordance with the second closed loop control algorithm instead of the first closed loop control algorithm, and controlling the medication delivery device in accordance with the second closed loop control algorithm. The control unit is configured to transmit one or more closed loop control operations to control the medication delivery device.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: April 4, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc Barry Taub, Daniel Milfred Bernstein, Gary Alan Hayter, Mark Kent Sloan, Glenn Howard Berman, Saeed Nekoomaram
  • Publication number: 20230066611
    Abstract: A method of calibrating an analyte measurement system is provided.
    Type: Application
    Filed: October 25, 2022
    Publication date: March 2, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Wesley Scott Harper, Glenn Howard Berman, Jean Mei Huang
  • Publication number: 20230046619
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: November 2, 2022
    Publication date: February 16, 2023
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20220359074
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 10, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Patent number: 11478173
    Abstract: A method of calibrating an analyte measurement system is provided.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: October 25, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc Barry Taub, Wesley Scott Harper, Glenn Howard Berman, Jean Mei Huang
  • Publication number: 20220133180
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 5, 2022
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20220071518
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 10, 2022
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20220071526
    Abstract: Methods and Devices to monitor the level of at least one analyte are provided.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 10, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Jolyon Robert Bugler, Thomas A. Peyser
  • Patent number: 11179068
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: November 23, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Publication number: 20210322676
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an adverse condition associated with the monitored physiological condition or the medication administration deviating from a predetermined safety level of the closed loop control operation, and initiating a non-zero pre-programmed medication delivery rate are provided.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Marc Barry Taub, Daniel Milfred Bernstein, Mark Kent Sloan
  • Publication number: 20210315493
    Abstract: Devices associated with on-body analyte sensor units are disclosed. These devices include any of packaging and/or loading systems, applicators and elements of the on-body sensor units themselves. Also, various approaches to connecting electrochemical analyte sensors to and/or within associated on-body analyte sensor units are disclosed. The connector approaches variously involve the use of unique sensor and ancillary element arrangements to facilitate assembly of separate electronics assemblies and sensor elements that are kept apart until the end user brings them together.
    Type: Application
    Filed: June 24, 2021
    Publication date: October 14, 2021
    Inventors: Louis Pace, Peter G. Robinson, Udo Hoss, Samuel Mason Curry, Phillip William Carter, Vincent Michael DiPalma, Amit Mhatre, Jennifer Olson, Manuel Luis Miguel Donnay, Marc Barry Taub
  • Patent number: D962446
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: August 30, 2022
    Assignee: ABBOTT DIABETES CARE, INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Lei He, Gary Alan Hayter, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub